Title: A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovarian syndrome
Authors: Neena Agrawal, Pallavi Kumari
DOI: https://dx.doi.org/10.18535/jmscr/v7i2.202
Abstract
Objective: To compare N-acetyl cysteine (NAC) with metformin on polycystic ovary syndrome (PCOS).
Method: Study was performed in two groups by randomized double blind clinical trial, in women with diagnosed PCOS without additional complication. In one group oral NAC 600mg, three times a day and in other group oral metformin 500mg, three times a day was prescribed for 24 weeks duration. After completion of this duration of treatment Fasting blood glucose (FBS), insulin, lipid profile, Homeostasis model assessment (HOMA) index were measured. The entire blood sample was taken in fasting state and was compared in two groups.
Result: Fifty women in NAC group and fifty women in metformin group finished the study. High-density lipoprotein was higher in NAC group.
Conclusion: NAC can improve lipid profile and fasting blood sugar and fasting blood insulin better than metformin.
Keywords: Abnormal uterine bleeding, BMI, fasting blood insulin, fasting blood glucose, insulin resistance, lipid profile-acetyl cysteine, metformin, polycystic ovarian syndrome.
References
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long – term health risks related to polycystic ovary syndrome .Hum Reprod 2004; 19:42-7
- Stankiewicz M, Norman R, Diagnosis and management of polycystic ovarian syndrome: a practical guide, Drugs 2006; 66:903-907
- Yasmin E, Balen AH, Management of polycystic ovary syndrome, Women’s Health (Lond Engl) 2007; 3:355-67
- Teede H, Deeks A, Moran L, polycystic ovary syndrome; a complex condition with psychological, reproductive and metabolic manifestations that impact on health across the lifespan, BMC Med 2010; 8:41
- Oner G, Muderiss II, clinical, endocrine and metabolic effect of metformin vs N-acetyl cysteine in women with polycystic ovarian syndrome .Eur j Obset Gynecol Reprod Biol 2011:159:159:127-31.
- Barber TM, Franks S. Genetics of polycystic ovary syndrome, Front Horm Res 2013; 40:28-39
- Saha L, Kaur S, Saha Pk.N-acetyl cysteine in clomiphene citrate resistant polycystic ovarian syndrome; a review of reported outcomes. J Pharmacol Pharmacother 2013:4:187-91.
- Sprizer PM, Polycystic ovarian syndrome: reviewing diagnosis and management of metabolic distubances, Arq Bras Endocrinol metabol 2014:58:182-7.
- Rocca Ml, Venturella, Mocciaro R, et al. Polycystic syndrome: chemical pharmacotherapy. Expert opin pharmacotherapy 2015:16:1369-93
- Pasquali R, Metformin in women with PCOS pros. Endocrine 2015:48:422-6.